Hope S. Rugo
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Hope S. Rugo
Jun 22, 2024, 00:42 |
Blog
Results from AMEERA-5 published in Journal of Clinical Oncology
Paolo Tarantino shared a post on X: "Results from AMEERA-5 published in Journal of Clinical Oncology.…
Jun 12, 2024, 07:37 |
Blog
Hope S. Rugo on Breast Cancer Research 'Lessons from the Past Will Shape the Future' - Media Medic
Media Medic posted on LinkedIn: "At the 2024 ESMO BC conference, Professor Hope S. Rugo,…
May 31, 2024, 17:02 |
Insight
Yakup Ergün: A guide where we can find answers to every question about aBC
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on…
Apr 29, 2024, 14:18 |
Drugs
Matthew Goetz: Abemacicib in high risk ER+/HER2 negative breast cancer
Matthew Goetz, Professor of Oncology and Pharmacology at Mayo Clinic, shared on LinkedIn: “An important…
All:
4
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube